查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713646

2025年全球定期健康體檢市場報告

Routine Health Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年定期健康體檢市場規模將強勁成長。到 2029 年，這一數字將成長至 777.6 億美元，年複合成長率（CAGR）為 7.4%。預測期內的成長歸因於個人化醫療的日益普及、對慢性病管理的日益關注、新興市場的醫療保健涵蓋範圍的擴大、醫療保健支出的增加以及公共和私人對預防性醫療保健計劃的投資的增加。預測期內的關鍵趨勢包括整合人工智慧以提高診斷準確性、透過遠端醫療平台擴展健康檢查服務、由於公共衛生舉措而日益關注預防性醫療保健、透過行動醫療應用程式和數位健康平台增強病人參與以及開發基於先進生物標記的篩檢技術。

預計預防性醫療保健意識的提高將在未來推動常規篩檢市場的發展。預防性保健包括透過早期發現、改變生活方式和主動干預來預防疾病和健康狀況的實踐和措施。由於預防性醫療保健具有早期發現疾病、改善健康結果和降低成本等優勢，隨著公眾教育的加強和醫學的進步，人們的認知不斷提高。定期健康檢查有助於預防性醫療保健，可及早發現潛在的健康問題，從而及時干預並降低嚴重的風險。例如，英國國家醫療服務體系（NHS）在2023年5月報告稱，2023年3月共進行了2,302,400次診斷測試，比2022年3月增加了223,100次。截至2023年3月底，等待關鍵診斷測試的患者人數為1,628,300人，比2022年3月增加了59,400人。這表明，人們對預防性醫療保健的認知不斷提高，正在推動定期健康體檢市場的成長。

為了獲得競爭優勢，常規健康體檢市場的主要企業正專注於開發肺癌篩檢測試等先進的解決方案。這些測試的目的是在高風險族群中及早發現肺癌，甚至在症狀出現之前。例如，2023 年 10 月，美國診斷技術公司 DELFI Diagnostics, Inc. 推出了 FirstLook Lung 測試，這是一項旨在改善肺癌篩檢的創新血液檢查。 FirstLook Lung 使用片段組體學分析血液檢體中的無細胞 DNA (cfDNA) 模式，並採用先進的機器學習來區分癌症和非癌症模式。此測試的陰性預測值 (NPV) 為 99.7%，可準確識別可能的肺癌，同時減少不必要的低劑量 CT (LDCT) 掃描的需要。 FirstLook Lung 將被整合到常規血液檢測中，以提高篩檢率，特別是在服務不足的人群中。它還具有可擴展的全基因組機器學習平台，有可能擴展到全球其他癌症和治療監測。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球定期健康檢視PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球定期健康體檢市場：成長率分析
  • 全球定期健康體檢市場表現：規模與成長，2019-2024年
  • 全球定期健康體檢市場預測：2024-2029 年及 2034 年規模與成長
  • 全球常規體檢總目標市場（TAM）

第6章市場區隔

  • 全球定期健康體檢市場（按檢查類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 血糖值檢測
  • 腎功能檢查
  • 骨輪廓測試
  • 電解質測試
  • 肝功能檢查
  • 血脂檢測
  • 其他測試類型
  • 全球定期健康體檢市場（依樣本類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 血清
  • 唾液
  • 其他樣本類型
  • 全球定期體檢市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定量聚合酵素鏈鎖反應（QPCR）
  • 定量螢光原位雜合反應（Q-FISH）
  • 免疫檢測
  • 醫學影像
  • 單端粒長度分析（STELA）
  • 其他技術
  • 全球常規健康體檢市場依樣本採集地點、表現及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 住宅
  • 診斷實驗室
  • 辦公室
  • 其他樣本採集地點
  • 全球定期健康體檢市場依血糖值測試類型、表現及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 空腹血糖值檢測
  • HbA1c 檢測
  • 持續血糖監測
  • 全球定期健康體檢市場依腎功能檢查類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血清肌酸酐檢測
  • 血中尿素氮（BUN）檢測
  • 尿液檢查
  • 全球定期健康體檢市場骨骼輪廓測試細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血清鈣檢測
  • 磷酸鹽測試
  • 骨骼密度（BMD）測試
  • 全球定期健康體檢市場電解質測試細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血清鈉檢測
  • 血清鉀檢測
  • 血清氯化物檢測
  • 全球定期體檢市場按肝功能檢查類型、表現及預測的詳細情形（2019-2024 年、2024-2029 年及 2034 年）
  • 丙胺基轉移酶（ALT）檢測
  • 天門冬胺基轉移酶（AST）檢測
  • 膽紅素檢測
  • 全球常規健康體檢市場血脂檢測細分類型、表現及預測（2019-2024 年、2024-2029 年、2034 年）
  • 總膽固醇檢測
  • 低密度脂蛋白（LDL）檢測
  • 高密度脂蛋白（HDL）檢測
  • 全球定期健康體檢市場、其他檢查類型細分、按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 甲狀腺功能檢查
  • 全血球計數（CBC）
  • 前列腺特異性抗原（PSA）檢測

第7章 區域和國家分析

  • 全球定期健康體檢市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球定期健康體檢市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 定期健康體檢市場：競爭格局
  • 定期健康體檢市場：公司簡介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Illumina Inc.
  • SYNLAB International GmbH
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • RadNet Inc.
  • Opko Health Inc.
  • UNILABS
  • Amedes Holding GmbH
  • Natera Inc.
  • Grail Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年常規健康體檢市場：提供新機會的國家
  • 2029年常規健康體檢市場：細分領域蘊藏新機會
  • 2029年常規健康體檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33548

Routine health screening involves regular medical tests and check-ups designed to detect potential health issues before symptoms arise. These screenings are essential for monitoring overall health, identifying risk factors, and preventing serious conditions such as heart disease, diabetes, or cancer. Recommendations for screenings are typically based on factors such as age, gender, and health history, and they play a crucial role in maintaining long-term health and well-being.

The main types of routine health screenings include blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, and others. A blood glucose test measures the level of glucose (sugar) in the blood to detect or manage diabetes. Samples for these tests can be obtained from blood, urine, serum, saliva, and other sources. Technologies used in these screenings include quantitative polymerase chain reaction (QPCR), quantitative fluorescence in situ hybridization (Q-FISH), immunoassays, medical imaging, single telomere length analysis (STELA), and others. Sample collection sites for these tests may include hospitals, homes, diagnostic laboratories, offices, and other locations.

The routine health screening market research report is one of a series of new reports from The Business Research Company that provides routine health screening market statistics, including routine health screening industry global market size, regional shares, competitors with a routine health screening market share, detailed routine health screening market segments, market trends and opportunities, and any further data you may need to thrive in the routine health screening industry. This routine health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The routine health screening market size has grown strongly in recent years. It will grow from $54.28 billion in 2024 to $58.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the rising prevalence of chronic diseases, growing government initiatives for early disease detection, the aging global population, and the expansion of healthcare infrastructure.

The routine health screening market size is expected to see strong growth in the next few years. It will grow to $77.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the growing adoption of personalized medicine, increasing focus on chronic disease management, expansion of healthcare access in emerging markets, rising healthcare spending, and greater public and private investment in preventive health programs. Major trends in the forecast period include the integration of artificial intelligence for improved diagnostic accuracy, expansion of health screening services through telemedicine platforms, heightened focus on preventive care driven by public health initiatives, enhanced patient engagement through mobile health apps and digital health platforms, and the development of advanced biomarker-based screening technologies.

The growing awareness of preventive healthcare is expected to boost the routine health screenings market in the future. Preventive healthcare involves practices and measures aimed at preventing diseases and health conditions through early detection, lifestyle changes, and proactive interventions. Increased awareness of preventive healthcare is due to its advantages in early disease detection, improved health outcomes, and cost savings, driven by enhanced public education and medical advancements. Routine health screenings support preventive healthcare by identifying potential health issues early, enabling timely interventions, and reducing the risk of severe diseases. For example, the National Health Service (NHS) reported in May 2023 that 2,302,400 diagnostic tests were conducted in March 2023, an increase of 223,100 tests compared to March 2022. By the end of March 2023, the number of patients waiting for a key diagnostic test had risen to 1,628,300, an increase of 59,400 from March 2022. This indicates that the rising awareness of preventive healthcare is driving growth in the routine health screenings market.

Leading companies in the routine health screenings market are focusing on developing advanced solutions, such as lung cancer screening tests, to gain a competitive advantage. These tests are designed to detect lung cancer early in individuals at high risk, even before symptoms appear. For instance, in October 2023, DELFI Diagnostics, Inc., a U.S.-based diagnostic technology company, launched the FirstLook Lung test, an innovative blood test aimed at improving lung cancer screening. FirstLook Lung uses fragmentomics to analyze patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to distinguish between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test accurately identifies potential lung cancer cases while reducing the need for unnecessary low-dose CT (LDCT) scans. FirstLook Lung is integrated into routine blood tests to improve screening rates, especially among underserved populations, and features a scalable whole-genome machine-learning platform that could potentially expand into other cancers and treatment monitoring globally.

In March 2024, Laboratory Corporation of America Holdings, a U.S.-based healthcare and diagnostics company, acquired BioReference Health from OPKO Health, Inc. for $237.5 million. This acquisition is intended to enhance Labcorp's capabilities and access in routine health screening. BioReference Health, a U.S.-based diagnostic laboratory company, offers testing services, including routine health screenings, oncology, urology, and reproductive and women's health tests.

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the routine health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The routine health screening market consists of revenues earned by entities by providing services such as health assessments, screening procedures, consultations, telehealth screenings, and corporate wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The routine health screening also includes sales of diagnostic test kits, medical devices, wearable health devices, and laboratory testing supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Routine Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on routine health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for routine health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The routine health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Blood Glucose Test; Kidney Function Test; Bone Profile Test; Electrolyte Test; Liver Function Test; Lipid Profile Test; Other Test Types
  • 2) By Sample Type: Blood; Urine; Serum; Saliva; Other Sample Types
  • 3) By Technology: Quantitative Polymerase Chain Reaction (QPCR); Quantitative Fluorescence In Situ Hybridization (Q-FISH); Immunoassays; Medical Imaging; Single Telomere Length Analysis (STELA); Other Technologies
  • 4) By Sample Collection Sites: Hospitals; Homes; Diagnostic Laboratories; Offices; Other Sample Collection Sites
  • Subsegments:
  • 1) By Blood Glucose Test: Fasting Blood Glucose Test; HbA1c Test; Continuous Glucose Monitoring
  • 2) By Kidney Function Test: Serum Creatinine Test; Blood Urea Nitrogen (BUN) Test; Urinalysis
  • 3) By Bone Profile Test: Serum Calcium Test; Phosphate Test; Bone Mineral Density (BMD) Test
  • 4) By Electrolyte Test: Serum Sodium Test; Serum Potassium Test; Serum Chloride Test
  • 5) By Liver Function Test: Alanine Aminotransferase (ALT) Test; Aspartate Aminotransferase (AST) Test; Bilirubin Test
  • 6) By Lipid Profile Test: Total Cholesterol Test; Low-Density Lipoprotein (LDL) Test; High-Density Lipoprotein (HDL) Test
  • 7) By Other Test Types: Thyroid Function Test; Complete Blood Count (CBC); Prostate-Specific Antigen (PSA) Test
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Siemens Healthineers; Laboratory Corporation; Quest Diagnostics Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Routine Health Screening Market Characteristics

3. Routine Health Screening Market Trends And Strategies

4. Routine Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Routine Health Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Routine Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Routine Health Screening Market Growth Rate Analysis
  • 5.4. Global Routine Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Routine Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Routine Health Screening Total Addressable Market (TAM)

6. Routine Health Screening Market Segmentation

  • 6.1. Global Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Test
  • Kidney Function Test
  • Bone Profile Test
  • Electrolyte Test
  • Liver Function Test
  • Lipid Profile Test
  • Other Test Types
  • 6.2. Global Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Serum
  • Saliva
  • Other Sample Types
  • 6.3. Global Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantitative Polymerase Chain Reaction (QPCR)
  • Quantitative Fluorescence In Situ Hybridization (Q-FISH)
  • Immunoassays
  • Medical Imaging
  • Single Telomere Length Analysis (STELA)
  • Other Technologies
  • 6.4. Global Routine Health Screening Market, Segmentation By Sample Collection Sites, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homes
  • Diagnostic Laboratories
  • Offices
  • Other Sample Collection Sites
  • 6.5. Global Routine Health Screening Market, Sub-Segmentation Of Blood Glucose Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fasting Blood Glucose Test
  • HbA1c Test
  • Continuous Glucose Monitoring
  • 6.6. Global Routine Health Screening Market, Sub-Segmentation Of Kidney Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Creatinine Test
  • Blood Urea Nitrogen (BUN) Test
  • Urinalysis
  • 6.7. Global Routine Health Screening Market, Sub-Segmentation Of Bone Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Calcium Test
  • Phosphate Test
  • Bone Mineral Density (BMD) Test
  • 6.8. Global Routine Health Screening Market, Sub-Segmentation Of Electrolyte Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Sodium Test
  • Serum Potassium Test
  • Serum Chloride Test
  • 6.9. Global Routine Health Screening Market, Sub-Segmentation Of Liver Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alanine Aminotransferase (ALT) Test
  • Aspartate Aminotransferase (AST) Test
  • Bilirubin Test
  • 6.10. Global Routine Health Screening Market, Sub-Segmentation Of Lipid Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Cholesterol Test
  • Low-Density Lipoprotein (LDL) Test
  • High-Density Lipoprotein (HDL) Test
  • 6.11. Global Routine Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thyroid Function Test
  • Complete Blood Count (CBC)
  • Prostate-Specific Antigen (PSA) Test

7. Routine Health Screening Market Regional And Country Analysis

  • 7.1. Global Routine Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Routine Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Routine Health Screening Market

  • 8.1. Asia-Pacific Routine Health Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Routine Health Screening Market

  • 9.1. China Routine Health Screening Market Overview
  • 9.2. China Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Routine Health Screening Market

  • 10.1. India Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Routine Health Screening Market

  • 11.1. Japan Routine Health Screening Market Overview
  • 11.2. Japan Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Routine Health Screening Market

  • 12.1. Australia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Routine Health Screening Market

  • 13.1. Indonesia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Routine Health Screening Market

  • 14.1. South Korea Routine Health Screening Market Overview
  • 14.2. South Korea Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Routine Health Screening Market

  • 15.1. Western Europe Routine Health Screening Market Overview
  • 15.2. Western Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Routine Health Screening Market

  • 16.1. UK Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Routine Health Screening Market

  • 17.1. Germany Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Routine Health Screening Market

  • 18.1. France Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Routine Health Screening Market

  • 19.1. Italy Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Routine Health Screening Market

  • 20.1. Spain Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Routine Health Screening Market

  • 21.1. Eastern Europe Routine Health Screening Market Overview
  • 21.2. Eastern Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Routine Health Screening Market

  • 22.1. Russia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Routine Health Screening Market

  • 23.1. North America Routine Health Screening Market Overview
  • 23.2. North America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Routine Health Screening Market

  • 24.1. USA Routine Health Screening Market Overview
  • 24.2. USA Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Routine Health Screening Market

  • 25.1. Canada Routine Health Screening Market Overview
  • 25.2. Canada Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Routine Health Screening Market

  • 26.1. South America Routine Health Screening Market Overview
  • 26.2. South America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Routine Health Screening Market

  • 27.1. Brazil Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Routine Health Screening Market

  • 28.1. Middle East Routine Health Screening Market Overview
  • 28.2. Middle East Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Routine Health Screening Market

  • 29.1. Africa Routine Health Screening Market Overview
  • 29.2. Africa Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Routine Health Screening Market Competitive Landscape And Company Profiles

  • 30.1. Routine Health Screening Market Competitive Landscape
  • 30.2. Routine Health Screening Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Routine Health Screening Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. Sonic Healthcare Limited
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. SYNLAB International GmbH
  • 31.7. Sysmex Corporation
  • 31.8. QIAGEN N.V.
  • 31.9. Exact Sciences Corporation
  • 31.10. RadNet Inc.
  • 31.11. Opko Health Inc.
  • 31.12. UNILABS
  • 31.13. Amedes Holding GmbH
  • 31.14. Natera Inc.
  • 31.15. Grail Inc.

32. Global Routine Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Routine Health Screening Market

34. Recent Developments In The Routine Health Screening Market

35. Routine Health Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Routine Health Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Routine Health Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Routine Health Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33548_Routine_Health_Screening_GMR_2025